|
1
|
Zulkifli MH, Abdullah ZL, Mohamed Yusof
NIS and Mohd Fauzi F: In silico toxicity studies of traditional
Chinese herbal medicine: A mini review. Curr Opin Struct Biol.
80:1025882023. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Qian Z, Wang GY, Henning M and Chen Y:
Understanding health literacy from a traditional Chinese medicine
perspective. J Integr Med. 21:215–220. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ai C, Zou Y, Liu H, Yang Z and Xi J:
Traditional Chinese herbal medicine for allergic diseases: A
review. Am J Chin Med. 51:779–806. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lu Y, Shao M, Xiang H, Wang J, Ji G and Wu
T: Qinggan huoxue recipe alleviates alcoholic liver injury by
suppressing endoplasmic reticulum stress through LXR-LPCAT3. Front
Pharmacol. 13:8241852022. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sun L, Yang Z, Zhao W, Chen Q, Bai H, Wang
S, Yang L, Bi C, Shi Y and Liu Y: Integrated lipidomics,
transcriptomics and network pharmacology analysis to reveal the
mechanisms of Danggui Buxue Decoction in the treatment of diabetic
nephropathy in type 2 diabetes mellitus. J Ethnopharmacol.
283:1146992022. View Article : Google Scholar
|
|
6
|
Xiang H, Shao M, Lu Y, Wang J, Wu T and Ji
G: Kaempferol alleviates steatosis and inf lammation during early
Non-Alcoholic steatohepatitis associated with liver X Receptor
α-Lysophosphatidylcholine acyltransferase 3 signaling pathway.
Front Pharmacol. 12:6907362021. View Article : Google Scholar
|
|
7
|
Paik S, Song GY and Jo EK: Ginsenosides
for therapeutically targeting inflammation through modulation of
oxidative stress. Int Immunopharmacol. 121:1104612023. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li J, Li F and Jin D: Ginsenosides are
promising medicine for tumor and inflammation: A review. Am J Chin
Med. 51:883–908. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zarneshan SN, Fakhri S and Khan H:
Targeting Akt/CREB/BDNF signaling pathway by ginsenosides in
neurodegenerative diseases: A mechanistic approach. Pharmacol Res.
177:1060992022. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Teng L, Guo X, Ma Y, Xu L, Wei J and Xiao
P: A comprehensive review on traditional and modern research of the
genus Bupleurum (Bupleurum L., Apiaceae) in recent 10 years. J
Ethnopharmacol. 306:1161292023. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sui C, Han WJ, Zhu CR and Wei JH: Recent
progress in saikosaponin biosynthesis in bupleurum. Curr Pharm
Biotechnol. 22:329–340. 2021. View Article : Google Scholar
|
|
12
|
Shao S, Jia R, Zhao L, Zhang Y, Guan Y,
Wen H, Liu J, Zhao Y, Feng Y, Zhang Z, et al: Xiao-Chai-Hu-Tang
ameliorates tumor growth in cancer comorbid depressive symptoms via
modulating gut microbiota-mediated TLR4/MyD88/NF-κB signaling
pathway. Phytomedicine. 88:1536062021. View Article : Google Scholar
|
|
13
|
Fan Q, Liu Y, Sheng L, Lv S, Yang L, Zhang
Z, Guo J, Fan Y and Hu D: Chaihu-Shugan-San inhibits
neuroinflammation in the treatment of post-stroke depression
through the JAK/STAT3-GSK3β/PTEN/Akt pathway. Biomed Pharmacother.
160:1143852023. View Article : Google Scholar
|
|
14
|
Jiao H, Fan Y, Gong A, Li T, Fu X and Yan
Z: Xiaoyaosan ameliorates CUMS-induced depressive-like and anorexia
behaviors in mice via necroptosis related cellular senescence in
hypothalamus. J Ethnopharmacol. 318:1169382024. View Article : Google Scholar
|
|
15
|
Luo K, Dai RJ, Zeng YB, Chang WJ, Deng YL
and Lv F: Triterpenoid saponins from Bupleurum marginatum and their
anti-liver fibrotic activities. J Asian Nat Prod Res. 26:858–864.
2024. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kang Y, Gao Y, Li X, Guo X, Liu Z, Li W,
Wei J and Qi Y: Bupleurum chinense exerts a mild antipyretic effect
on LPS-induced pyrexia rats involving inhibition of peripheral
TNF-α production. J Ethnopharmacol. 310:1163752023. View Article : Google Scholar
|
|
17
|
Zhou J, He X, Sun R, Yu Z, Wang C, Deng S,
Zhang B, Huang S, Han C and Li D: Lignans from Bupleurum marginatum
and their antioxidant activity. Nat Prod Res. 36:5016–5021. 2022.
View Article : Google Scholar
|
|
18
|
Sun P, Li Y, Wei S, Zhao T, Wang Y, Song
C, Xue L, Wang F, Xiao L, Wu J and Qiao M: Pharmacological effects
and chemical constituents of bupleurum. Mini Rev Med Chem.
19:34–55. 2019. View Article : Google Scholar
|
|
19
|
Li XQ, Song YN, Wang SJ, Rahman K, Zhu JY
and Zhang H: Saikosaponins: A review of pharmacological effects. J
Asian Nat Prod Res. 20:399–411. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang YJ, Wu SS, Chen XM, Pi JK, Cheng YF,
Zhang Y, Wang XJ, Luo D, Zhou JH, Xu JY, et al: Saikosaponin D
Alleviates DOX-induced cardiac injury in vivo and in vitro. J
Cardiovasc Pharmacol. 79:558–567. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang HW, Liu M, Zhong TD and Fang XM:
Saikosaponin-d attenuates ventilator-induced lung injury in rats.
Int J Clin Exp Med. 8:15137–15145. 2015.PubMed/NCBI
|
|
22
|
Li X, Ge J, Li Y, Cai Y, Zheng Q, Huang N,
Gu Y, Han Q, Li Y, Sun R, et al: Integrative lipidomic and
transcriptomic study unravels the therapeutic effects of
saikosaponins A and D on non-alcoholic fatty liver disease. Acta
Pharm Sin B. 11:3527–3541. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fan J, Li X, Li P, Li N, Wang T, Shen H,
Siow Y, Choy P and Gong Y: Saikosaponin-d attenuates the
development of liver fibrosis by preventing hepatocyte injury.
Biochem Cell Biol. 85:189–195. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yao T, Zhang L, Fu Y, Yao L, Zhou C and
Chen G: Saikosaponin-d alleviates renal inflammation and cell
apoptosis in a mouse model of sepsis via TCF7/FOSL1/matrix
metalloproteinase 9 inhibition. Mol Cell Biol. 41:e00332212021.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Xiang Q, Liu Y and Chen L: Saikosaponin d
(SSD) alleviates diabetic peripheral neuropathy by regulating the
AQP1/RhoA/ROCK signaling in streptozotocin-induced diabetic rats.
Acta Diabetol. 60:805–815. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gao T, Wang T, Wu L, Tong Y, Tian J, Zhao
K and Wang H: Saikosaponin-d alleviates depression by promoting
NLRP3 ubiquitination and inhibiting inflammasome activation. Int
Immunopharmacol. 127:1113242024. View Article : Google Scholar
|
|
27
|
Lixing X, Zhouye J, Liting G, Ruyi Z, Rong
Q and Shiping M: Saikosaponin-d-mediated downregulation of
neurogenesis results in cognitive dysfunction by inhibiting
Akt/Foxg-1 pathway in mice. Toxicol Lett. 284:79–85. 2018.
View Article : Google Scholar
|
|
28
|
Hu J, Li P, Shi B and Tie J: Effects and
mechanisms of saikosaponin D improving the sensitivity of human
gastric cancer cells to cisplatin. ACS Omega. 6:18745–18755. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen LL, Xia LY, Zhang JP, Wang Y, Chen
JY, Guo C and Xu WH: Saikosaponin D alleviates cancer cachexia by
directly inhibiting STAT3. Phytother Res. 37:809–819. 2023.
View Article : Google Scholar
|
|
30
|
Wang P, Ren J, Tang J, Zhang D, Li B and
Li Y: Estrogen-like activities of saikosaponin-d in vitro: A pilot
study. Eur J Pharmacol. 626:159–165. 2010. View Article : Google Scholar
|
|
31
|
Que R, Shen Y, Ren J, Tao Z, Zhu X and Li
Y: Estrogen receptor-β-dependent effects of saikosaponin-d on the
suppression of oxidative stress-induced rat hepatic stellate cell
activation. Int J Mol Med. 41:1357–1364. 2018.
|
|
32
|
Lin L, Zhou M, Que R, Chen Y, Liu X, Zhang
K, Shi Z and Li Y: Saikosaponin-d protects against liver fibrosis
by regulating the estrogen receptor-β/NLRP3 inflammasome pathway.
Biochem Cell Biol. 99:666–674. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhang K, Lin L, Zhu Y, Zhang N, Zhou M and
Li Y: Saikosaponin d alleviates liver fibrosis by negatively
regulating the ROS/NLRP3 inflammasome through activating the ERβ
pathway. Front Pharmacol. 13:8949812022. View Article : Google Scholar
|
|
34
|
Kumazawa Y, Takimoto H, Nishimura C,
Kawakita T and Nomoto K: Activation of murine peritoneal
macrophages by saikosaponin a, saikosaponin d and saikogenin d. Int
J Immunopharmacol. 11:21–28. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Luo SQ, Lin LZ and Cordell GA:
Saikosaponin derivatives from Bupleurum wenchuanense.
Phytochemistry. 33:1197–1205. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lu CN, Yuan ZG, Zhang XL, Yan R, Zhao YQ,
Liao M and Chen JX: Saikosaponin a and its epimer saikosaponin d
exhibit anti-inflammatory activity by suppressing activation of
NF-κB signaling pathway. Int Immunopharmacol. 14:121–126. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Li C, Cui L, Zhang L, Yang L, Zhuo Y, Cui
J, Cui N and Zhang S: Saikosaponin D attenuates pancreatic injury
through suppressing the apoptosis of acinar cell via modulation of
the MAPK signaling pathway. Front Pharmacol. 12:7350792021.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kassis S, Grondin M and Averill-Bates DA:
Heat shock increases levels of reactive oxygen species, autophagy
and apoptosis. Biochim Biophys Acta Mol Cell Res. 1868:1189242021.
View Article : Google Scholar
|
|
39
|
Zhang BZ, Guo XT, Chen JW, Zhao Y, Cong X,
Jiang ZL, Cao RF, Cui K, Gao SS and Tian WR: Saikosaponin-D
attenuates heat stress-induced oxidative damage in LLC-PK1 cells by
increasing the expression of anti-oxidant enzymes and HSP72. Am J
Chin Med. 42:1261–1277. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Lin X, Wu S, Wang Q, Shi Y, Liu G, Zhi J
and Wang F: Saikosaponin-D reduces H2O2-induced PC12 cell apoptosis
by removing ROS and blocking MAPK-dependent oxidative damage. Cell
Mol Neurobiol. 36:1365–1375. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Huang M, Yan Y, Deng Z, Zhou L, She M,
Yang Y, Zhang M and Wang D: Saikosaponin A and D attenuate skeletal
muscle atrophy in chronic kidney disease by reducing oxidative
stress through activation of PI3K/AKT/Nrf2 pathway. Phytomedicine.
114:1547662023. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Su W, Huang S, Zhu H, Zhang B and Wu X:
Interaction between PHB2 and Enterovirus A71 VP1 Induces Autophagy
and Affects EV-A71 Infection. Viruses. 12:4142020. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Li C, Huang L, Sun W, Chen Y, He ML, Yue J
and Ballard H: Saikosaponin D suppresses enterovirus A71 infection
by inhibiting autophagy. Signal Transduct Target Ther. 4:42019.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Sun J, Zheng J, Shi X, Qian H, Jin C and
Xu L: Saikosaponin D inhibits proliferation and collagen production
of human embryonic lung fibroblasts by regulating TGF-β1/Smads
signaling pathway. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 35:256–261.
2019.In Chinese. PubMed/NCBI
|
|
45
|
Du P, Xu J, Jiang Y, Zhao J, Gao C, Fang
Y, Yang X, Yang YP and Zhang JA: Saikosaponin-d attenuates
hashimoto's thyroiditis by regulating macrophage polarization. J
Immunol Res. 2022:74554942022. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Chen X, Liu C, Zhao R, Zhao P, Wu J, Zhou
N and Ying M: Synergetic and antagonistic molecular effects
mediated by the feedback loop of p53 and JNK between Saikosaponin D
and SP600125 on lung cancer A549 cells. Mol Pharm. 15:4974–4984.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Lai M, Ge Y, Chen M, Sun S, Chen J and
Cheng R: Saikosaponin D inhibits proliferation and promotes
apoptosis through activation of MKK4-JNK signaling pathway in
pancreatic cancer cells. Onco Targets Ther. 13:9465–9479. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Wu S, Chen W, Liu K, Ren F, Zheng D, Xu F
and Wu H: Saikosaponin D inhibits proliferation and induces
apoptosis of non-small cell lung cancer cells by inhibiting the
STAT3 pathway. J Int Med Res. 48:3000605209371632020. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Wang J, Qi H, Zhang X, Si W, Xu F, Hou T,
Zhou H, Wang A, Li G, Liu Y, et al: Saikosaponin D from Radix
Bupleuri suppresses triple-negative breast cancer cell growth by
targeting β-catenin signaling. Biomed Pharmacother. 108:724–733.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Chen M, Hu C, Yang L, Guo Q, Liang Y and
Wang W: Saikosaponin-D induces the pyroptosis of lung cancer by
increasing ROS and activating the NF-κB/NLRP3/caspase-1/GSDMD
pathway. J Biochem Mol Toxicol. 37:e234442023. View Article : Google Scholar
|
|
51
|
Li P, Gong Y, Zu N, Li Y, Wang B and
Shimizu F: Therapeutic mechanism of Saikosaponin-d in anti-Thy1 mAb
1-22-3-induced rat model of glomerulonephritis. Nephron Exp
Nephrol. 101:e111–118. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Hsu YL, Kuo PL and Lin CC: The
proliferative inhibition and apoptotic mechanism of Saikosaponin D
in human non-small cell lung cancer A549 cells. Life Sci.
75:1231–1242. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Wong VK, Zhang MM, Zhou H, Lam KY, Chan
PL, Law CK, Yue PY and Liu L: Saikosaponin-d enhances the
anticancer potency of TNF-α via overcoming its undesirable response
of activating NF-Kappa B signalling in cancer cells. Evid Based
Complement Alternat Med. 2013:7452952013. View Article : Google Scholar
|
|
54
|
Rawat PS, Jaiswal A, Khurana A, Bhatti JS
and Navik U: Doxorubicin-induced cardiotoxicity: An update on the
molecular mechanism and novel therapeutic strategies for effective
management. Biomed Pharmacother. 139:1117082021. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Song L, Lu G and Tao Y: Saikosaponin D
attenuates inflammatory response and cell apoptosis of
lipopolysaccharide-induced lung epithelial cells. Clin Respir J.
17:1017–1024. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Moss BJ, Ryter SW and Rosas IO: Pathogenic
mechanisms underlying idiopathic pulmonary fibrosis. Annu Rev
Pathol. 17:515–546. 2022. View Article : Google Scholar
|
|
57
|
Wu Y, Zhang J, Wang X, Xu Y and Zheng J:
Saikosaponin-d regulates angiogenesis in idiopathic pulmonary
fibrosis through angiopoietin/Tie-2 pathway. Acta Histochem.
125:1521002023. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Jaeschke H, Akakpo JY, Umbaugh DS and
Ramachandran A: Novel therapeutic approaches against
acetaminophen-induced liver injury and acute liver failure. Toxicol
Sci. 174:159–167. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Liu A, Tanaka N, Sun L, Guo B, Kim JH,
Krausz KW, Fang Z, Jiang C, Yang J and Gonzalez FJ: Saikosaponin d
protects against acetaminophen-induced hepatotoxicity by inhibiting
NF-κB and STAT3 signaling. Chem Biol Interact. 223:80–86. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Lin L, Que R, Shen Y, Chen Y, Yan N and Li
Y: Saikosaponin-d alleviates carbon-tetrachloride induced acute
hepatocellular injury by inhibiting oxidative stress and NLRP3
inflammasome activation in the HL-7702 cell line. Mol Med Rep.
17:7939–7946. 2018.PubMed/NCBI
|
|
61
|
Chen Y, Que R, Lin L, Shen Y, Liu J and Li
Y: Inhibition of oxidative stress and NLRP3 inflammasome by
Saikosaponin-d alleviates acute liver injury in carbon
tetrachloride-induced hepatitis in mice. Int J Immunopathol
Pharmacol. 34:20587384209505932020. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Singal AK, Bataller R, Ahn J, Kamath PS
and Shah VH: ACG Clinical Guideline: Alcoholic liver disease. Am J
Gastroenterol. 113:175–194. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Tsuchida T and Friedman SL: Mechanisms of
hepatic stellate cell activation. Nat Rev Gastroenterol Hepatol.
14:397–411. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Jiang H, Liu J, Zhang K and Zeng Q:
Saikosaponin D inhibits the proliferation and promotes the
apoptosis of rat hepatic stellate cells by inducing autophagosome
formation. Evid Based Complement Alternat Med. 2021:54517582021.
View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Yu X, Pan J, Shen N, Zhang H, Zou L, Miao
H and Xing L: Development of Saikosaponin D liposome nanocarrier
with increased hepatoprotective effect against alcoholic hepatitis
mice. J Biomed Nanotechnol. 17:627–639. 2021. View Article : Google Scholar
|
|
66
|
Byrne CD and Targher G: NAFLD: A
multisystem disease. J Hepatol. 62(1 Suppl): S47–S64. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Lim SH, Lee HS, Han HK and Choi CI:
Saikosaponin A and D inhibit adipogenesis via the AMPK and MAPK
signaling pathways in 3T3-L1 adipocytes. Int J Mol Sci.
22:114092021. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Gu Y, Duan S, Ding M, Zheng Q, Fan G, Li
X, Li Y, Liu C, Sun R and Liu R: Saikosaponin D attenuates
metabolic associated fatty liver disease by coordinately tuning
PPARα and INSIG/SREBP1c pathway. Phytomedicine. 103:1542192022.
View Article : Google Scholar
|
|
69
|
Abe H, Sakaguchi M, Odashima S and Arichi
S: Protective effect of saikosaponin-d isolated from Bupleurum
falcatum L. on CCl4-induced liver injury in the rat. Naunyn
Schmiedebergs Arch Pharmacol. 320:266–271. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Dang SS, Wang BF, Cheng YA, Song P, Liu ZG
and Li ZF: Inhibitory effects of saikosaponin-d on CCl4-induced
hepatic fibrogenesis in rats. World J Gastroenterol. 13:557–563.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Chen MF, Huang CC, Liu PS, Chen CH and
Shiu LY: Saikosaponin a and saikosaponin d inhibit proliferation
and migratory activity of rat HSC-T6 cells. J Med Food. 16:793–800.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Chen MF, Huang SJ, Huang CC, Liu PS, Lin
KI, Liu CW, Hsieh WC, Shiu LY and Chen CH: Saikosaponin d induces
cell death through caspase-3-dependent, caspase-3-independent and
mitochondrial pathways in mammalian hepatic stellate cells. BMC
Cancer. 16:5322016. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Chen Y, Que R, Zhang N, Lin L, Zhou M and
Li Y: Saikosaponin-d alleviates hepatic fibrosis through regulating
GPER1/autophagy signaling. Mol Biol Rep. 48:7853–7863. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Zeng Y, Zhou L, Wan Y, Fu T, Xu P, Zhang H
and Guan Y: Effects of Saikosaponin D on apoptosis, autophagy, and
morphological structure of intestinal cells of cajal with
functional dyspepsia. Comb Chem High Throughput Screen.
27:1513–1522. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Li P, Wu M, Xiong W, Li J, An Y, Ren J,
Xie Y, Xue H, Yan D, Li M, et al: Saikosaponin-d ameliorates
dextran sulfate sodium-induced colitis by suppressing NF-κB
activation and modulating the gut microbiota in mice. Int
Immunopharmacol. 81:1062882020. View Article : Google Scholar
|
|
76
|
Habtezion A: Inflammation in acute and
chronic pancreatitis. Curr Opin Gastroenterol. 31:395–399. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Cui LH, Li CX, Zhuo YZ, Yang L, Cui NQ and
Zhang SK: Saikosaponin d ameliorates pancreatic fibrosis by
inhibiting autophagy of pancreatic stellate cells via PI3K/Akt/mTOR
pathway. Chem Biol Interact. 300:18–26. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Abe H, Orita M, Konishi H, Arichi S and
Odashima S: Effects of saikosaponin-d on aminonucleoside nephrosis
in rats. Eur J Pharmacol. 120:171–178. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Zhao L, Zhang H, Bao J, Liu J and Ji Z:
Saikosaponin-d protects renal tubular epithelial cell against high
glucose induced injury through modulation of SIRT3. Int J Clin Exp
Med. 8:6472–6481. 2015.PubMed/NCBI
|
|
80
|
Kidney Disease: Improving Global Outcomes
(KDIGO) CKD Work Group: KDIGO 2024 clinical practice guideline for
the evaluation and management of chronic kidney disease. Kidney
Int. 105(Suppl): S117–S314. 2024. View Article : Google Scholar
|
|
81
|
Loren P, Lugones Y, Saavedra N, Saavedra
K, Páez I, Rodriguez N, Moriel P and Salazar LA: MicroRNAs involved
in intrinsic apoptotic pathway during Cisplatin-induced
nephrotoxicity: Potential use of natural products against
DDP-induced apoptosis. Biomolecules. 12:12062022. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Ma X, Dang C, Kang H, Dai Z, Lin S, Guan
H, Liu X, Wang X and Hui W: Saikosaponin-D reduces
cisplatin-induced nephrotoxicity by repressing ROS-mediated
activation of MAPK and NF-κB signalling pathways. Int
Immunopharmacol. 28:399–408. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Tomino Y: Mechanisms and interventions in
peritoneal fibrosis. Clin Exp Nephrol. 16:109–114. 2012. View Article : Google Scholar
|
|
84
|
Ruiqi L, Ming P, Qihang S, Yangyang L,
Junli C, Wei L, Chao G, Xinyue L, Kang Y and Hongtao Y:
Saikosaponin D inhibits peritoneal fibrosis in rats with renal
failure by regulation of TGFβ1/BMP7/Gremlin1/Smad pathway. Front
Pharmacol. 12:6286712021. View Article : Google Scholar
|
|
85
|
Sun Y, Zhang H, Zhang X, Wang W, Chen Y,
Cai Z, Wang Q, Wang J and Shi Y: Promotion of astrocyte-neuron
glutamate-glutamine shuttle by SCFA contributes to the alleviation
of Alzheimer's disease. Redox Biol. 62:1026902023. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Bai R, Guo J, Ye XY, Xie Y and Xie T:
Oxidative stress: The core pathogenesis and mechanism of
Alzheimer's disease. Ageing Res Rev. 77:1016192022. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Du J, Song D, Li Y, Liu J, Huang X, Li B
and Li L: Saikosaponin-D mitigates oxidation in SH-SY5Y cells
stimulated by glutamate through activation of Nrf2 pathway:
Involvement of PI3K. Neurotox Res. 40:230–240. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Qin T, Yuan Z, Yu J, Fu X, Deng X, Fu Q,
Ma Z and Ma S: Saikosaponin-d impedes hippocampal neurogenesis and
causes cognitive deficits by inhibiting the survival of neural
stem/progenitor cells via neurotrophin receptor signaling in mice.
Clin Transl Med. 10:e2432020. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Smith K: Mental health: A world of
depression. Nature. 515:1812014. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Li HY, Zhao YH, Zeng MJ, Fang F, Li M, Qin
TT, Ye LY, Li HW, Qu R and Ma SP: Saikosaponin D relieves
unpredictable chronic mild stress induced depressive-like behavior
in rats: Involvement of HPA axis and hippocampal neurogenesis.
Psychopharmacology (Berl). 234:3385–3394. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Chao B, Huang S, Pan J, Zhang Y and Wang
Y: Saikosaponin d downregulates microRNA-155 and upregulates FGF2
to improve depression-like behaviors in rats induced by
unpredictable chronic mild stress by negatively regulating NF-κB.
Brain Res Bull. 157:69–76. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Liu CY, Chen JB, Liu YY, Zhou XM, Zhang M,
Jiang YM, Ma QY, Xue Z, Zhao ZY, Li XJ, et al: Saikosaponin D
exerts antidepressant effect by regulating Homer1-mGluR5 and mTOR
signaling in a rat model of chronic unpredictable mild stress. Chin
Med. 17:602022. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Su J, Pan YW, Wang SQ, Li XZ, Huang F and
Ma SP: Saikosaponin-d attenuated lipopolysaccharide-induced
depressive-like behaviors via inhibiting microglia activation and
neuroinflammation. Int Immunopharmacol. 80:1061812020. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Papatheodorou K, Banach M, Bekiari E,
Rizzo M and Edmonds M: Complications of Diabetes 2017. J Diabetes
Res. 2018:30861672018. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Ralli M, Angeletti D, Fiore M, D'Aguanno
V, Lambiase A, Artico M, de Vincentiis M and Greco A: Hashimoto's
thyroiditis: An update on pathogenic mechanisms, diagnostic
protocols, therapeutic strategies, and potential malignant
transformation. Autoimmun Rev. 19:1026492020. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Martel-Pelletier J, Barr AJ, Cicuttini FM,
Conaghan PG, Cooper C, Goldring MB, Goldring SR, Jones G, Teichtahl
AJ and Pelletier JP: Osteoarthritis. Nat Rev Dis Primers.
2:160722016. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Jiang J, Meng Y, Hu S, Botchway BOA, Zhang
Y and Liu X: Saikosaponin D: A potential therapeutic drug for
osteoarthritis. J Tissue Eng Regen Med. 14:1175–1184. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Wu X, Zhao K, Fang X, Lu F, Cheng P, Song
X, Zhang W, Yao C, Zhu J and Chen H: Saikosaponin D inhibited IL-1β
induced ATDC 5 chondrocytes apoptosis in vitro and delayed
articular cartilage degeneration in OA model mice in vivo. Front
Pharmacol. 13:8459592022. View Article : Google Scholar
|
|
99
|
Yan M, Zhang D and Yang M: Saikosaponin D
alleviates inflammatory response of osteoarthritis and mediates
autophagy via elevating microRNA-199-3p to target transcription
Factor-4. J Orthop Surg Res. 19:1512024. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Liu RY and Li JP: Saikosaponin-d inhibits
proliferation of human undifferentiated thyroid carcinoma cells
through induction of apoptosis and cell cycle arrest. Eur Rev Med
Pharmacol Sci. 18:2435–2443. 2014.PubMed/NCBI
|
|
101
|
Passaro A, Jänne PA, Mok T and Peters S:
Overcoming therapy resistance in EGFR-mutant lung cancer. Nat
Cancer. 2:377–391. 2021. View Article : Google Scholar
|
|
102
|
Tang JC, Long F, Zhao J, Hang J, Ren YG,
Chen JY and Mu B: The Effects and mechanisms by which
Saikosaponin-D enhances the sensitivity of human non-small cell
lung cancer cells to gefitinib. J Cancer. 10:6666–6672. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Dong J, Yuan L, Hu C, Cheng X and Qin JJ:
Strategies to overcome cancer multidrug resistance (MDR) through
targeting P-glycoprotein (ABCB1): An updated review. Pharmacol
Ther. 249:1084882023. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Li C, Guan X, Xue H, Wang P, Wang M and
Gai X: Reversal of P-glycoprotein-mediated multidrug resistance is
induced by saikosaponin D in breast cancer MCF-7/adriamycin cells.
Pathol Res Pract. 213:848–853. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Li C, Xue HG, Feng LJ, Wang ML, Wang P and
Gai XD: The effect of saikosaponin D on doxorubicin
pharmacokinetics and its MDR reversal in MCF-7/adr cell xenografts.
Eur Rev Med Pharmacol Sci. 21:4437–4445. 2017.PubMed/NCBI
|
|
106
|
Fu R, Zhang L, Li Y, Li B, Ming Y, Li Z,
Xing H and Chen J: Saikosaponin D inhibits autophagosome-lysosome
fusion and induces autophagy-independent apoptosis in MDA-MB-231
breast cancer cells. Mol Med Rep. 22:1026–1034. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Yang T, Li X, Wang X, Meng X, Zhang Z,
Zhao M and Su R: Combination of histological and metabolomic
assessments to evaluate the potential pharmacological efficacy of
saikosaponin D. J Pharm Biomed Anal. 242:1160012024. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Wen N, Cai Y, Li F, Ye H, Tang W, Song P
and Cheng N: The clinical management of hepatocellular carcinoma
worldwide: A concise review and comparison of current guidelines:
2022 update. Biosci Trends. 16:20–30. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Jia X, Dang S, Cheng Y, Zhang X, Li M, Li
Y and Li S: Effects of saikosaponin-d on syndecan-2, matrix
metalloproteinases and tissue inhibitor of metalloproteinases-2 in
rats with hepatocellular carcinoma. J Tradit Chin Med. 32:415–422.
2012. View Article : Google Scholar
|
|
110
|
Chen Y, Chen HN, Wang K, Zhang L, Huang Z,
Liu J, Zhang Z, Luo M, Lei Y, Peng Y, et al: Ketoconazole
exacerbates mitophagy to induce apoptosis by downregulating
cyclooxygenase-2 in hepatocellular carcinoma. J Hepatol. 70:66–77.
2019. View Article : Google Scholar
|
|
111
|
Pang C, Miao H, Zuo Y, Guo N, Sun D and Li
B: C/EBPβ enhances efficacy of sorafenib in hepatoblastoma. Cell
Biol Int. 45:1897–1905. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
He SX, Luo JY, Zhao G, Xu JL, Wang YL, Fu
H and Dong L: Effect of saikosaponins-d on cyclooxygenase-2
expression of human hepatocellular carcinoma cell line SMMC-7721.
Zhonghua Gan Zang Bing Za Zhi. 14:712–714. 2006.In Chinese.
PubMed/NCBI
|
|
113
|
Lu XL, He SX, Ren MD, Wang YL, Zhang YX
and Liu EQ: Chemopreventive effect of saikosaponin-d on
diethylinitrosamine-induced hepatocarcinogenesis: Involvement of
CCAAT/enhancer binding protein β and cyclooxygenase-2. Mol Med Rep.
5:637–644. 2012.
|
|
114
|
He S, Lu G, Hou H, Zhao Z, Zhu Z, Lu X,
Chen J and Wang Z: Saikosaponin-d suppresses the expression of
cyclooxygenase-2 through the phospho-signal transducer and
activator of transcription 3/hypoxia-inducible factor-1α pathway in
hepatocellular carcinoma cells. Mol Med Rep. 10:2556–2562. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Ren M, McGowan E, Li Y, Zhu X, Lu X, Zhu
Z, Lin Y and He S: Saikosaponin-d Suppresses COX2 Through
p-STAT3/C/EBPβ signaling pathway in liver cancer: A novel mechanism
of action. Front Pharmacol. 10:6232019. View Article : Google Scholar
|
|
116
|
Wang BF, Dai ZJ, Wang XJ, Bai MH, Lin S,
Ma HB, Wang YL, Song LQ, Ma XL, Zan Y, et al: Saikosaponin-d
increases the radiosensitivity of smmc-7721 hepatocellular
carcinoma cells by adjusting the g0/g1 and g2/m checkpoints of the
cell cycle. BMC Complement Altern Med. 13:2632013. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Wang BF, Wang XJ, Kang HF, Bai MH, Guan
HT, Wang ZW, Zan Y, Song LQ, Min WL, Lin S, et al: Saikosaponin-D
enhances radiosensitivity of hepatoma cells under hypoxic
conditions by inhibiting hypoxia-inducible factor-1α. Cell Physiol
Biochem. 33:37–51. 2014. View Article : Google Scholar
|
|
118
|
Ciepla P, Konitsiotis AD, Serwa RA,
Masumoto N, Leong WP, Dallman MJ, Magee AI and Tate EW: New
chemical probes targeting cholesterylation of Sonic Hedgehog in
human cells and zebrafish. Chem Sci. 5:4249–4259. 2014. View Article : Google Scholar
|
|
119
|
Zhang Z, Zhan X, Kim B and Wu J: A
proteomic approach identifies SAFB-like transcription modulator
(SLTM) as a bidirectional regulator of GLI family zinc finger
transcription factors. J Biol Chem. 294:5549–5561. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Hendriks IA and Vertegaal AC: A
comprehensive compilation of SUMO proteomics. Nat Rev Mol Cell
Biol. 17:581–595. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Zhang CY, Jiang ZM, Ma XF, Li Y, Liu XZ,
Li LL, Wu WH and Wang T: Saikosaponin-d Inhibits the hepatoma cells
and enhances chemosensitivity through SENP5-dependent inhibition of
Gli1 SUMOylation under hypoxia. Front Pharmacol. 10:10392019.
View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Tian YD, Lin S, Yang PT, Bai MH, Jin YY,
Min WL, Ma HB and Wang BF: Saikosaponin-d increases the
radiosensitivity of hepatoma cells by adjusting cell autophagy. J
Cancer. 10:4947–4953. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Wang B, Min W, Lin S, Song L, Yang P, Ma Q
and Guo J: Saikosaponin-d increases radiation-induced apoptosis of
hepatoma cells by promoting autophagy via inhibiting mTOR
phosphorylation. Int J Med Sci. 18:1465–1473. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Lv Y, Hou X, Zhang Q, Li R, Xu L, Chen Y,
Tian Y, Sun R, Zhang Z and Xu F: Untargeted metabolomics study of
the in vitro anti-hepatoma effect of saikosaponin d in combination
with NRP-1 knockdown. Molecules. 24:14232019. View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Li H, Tang Y, Wang Y, Wei W, Yin C and
Tang F: Effects of Saikosaponin D on CYP1A2 and CYP2D6 in HepaRG
cells. Drug Des Devel Ther. 14:5251–5258. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Li H, Tang Y, Wei W, Yin C and Tang F:
Effects of saikosaponin-d on CYP3A4 in HepaRG cell and
protein-ligand docking study. Basic Clin Pharmacol Toxicol.
128:661–668. 2021. View Article : Google Scholar
|
|
127
|
Edeline J, Bridgewater J, Campillo-Gimenez
B, Neveu E, Phelip JM, Neuzillet C, Boudjema K, Rolland Y, Valle
JW, Garin E, et al: Chemotherapy with or without selective internal
radiation therapy for intrahepatic cholangiocarcinoma: Data from
clinical trials. Hepatology. 79:96–106. 2024. View Article : Google Scholar
|
|
128
|
Kelley RK, Bridgewater J, Gores GJ and Zhu
AX: Systemic therapies for intrahepatic cholangiocarcinoma. J
Hepatol. 72:353–363. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Kanno N, Lesage G, Phinizy JL, Glaser S,
Francis H and Alpini G: Stimulation of alpha2-adrenergic receptor
inhibits cholangiocarcinoma growth through modulation of Raf-1 and
B-raf activities. Hepatology. 35:1329–1340. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
130
|
He H, Guo J, Hu Y, Zhang H, Li X, Zhang J
and Jin S: Saikosaponin D reverses epinephrine- and
norepinephrine-induced gemcitabine resistance in intrahepatic
cholangiocarcinoma by downregulating ADRB2/glycolysis signaling.
Acta Biochim Biophys Sin (Shanghai). 55:1404–1414. 2023.PubMed/NCBI
|
|
131
|
Smyth EC, Nilsson M, Grabsch HI, van
Grieken NC and Lordick F: Gastric cancer. Lancet. 396:635–648.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
132
|
Ning N, Li X, Nan Y, Chen G, Huang S, Du
Y, Gu Q, Li W and Yuan L: Molecular mechanism of Saikosaponin-d in
the treatment of gastric cancer based on network pharmacology and
in vitro experimental verification. Naunyn Schmiedebergs Arch
Pharmacol. 397:8943–8959. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Klein AP: Pancreatic cancer epidemiology:
Understanding the role of lifestyle and inherited risk factors. Nat
Rev Gastroenterol Hepatol. 18:493–502. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
134
|
Xu X, Cui L, Zhang L, Yang L, Zhuo Y and
Li C: Saikosaponin d modulates the polarization of tumor-associated
macrophages by deactivating the PI3K/AKT/mTOR pathway in murine
models of pancreatic cancer. Int Immunopharmacol. 122:1105792023.
View Article : Google Scholar : PubMed/NCBI
|
|
135
|
Cai C, Zhang H, Ou Y, Jiang Y, Zhong D, Qi
H and Dang Q: Saikosaponin-d suppresses cell growth in renal cell
carcinoma through EGFR/p38 signaling pathway. Neoplasma.
64:518–525. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
136
|
Rizzo A, Santoni M, Mollica V, Fiorentino
M, Brandi G and Massari F: Microbiota and prostate cancer. Semin
Cancer Biol. 86:1058–1065. 2022. View Article : Google Scholar
|
|
137
|
Yao M, Yang J, Cao L, Zhang L, Qu S and
Gao H: Saikosaponin-d inhibits proliferation of DU145 human
prostate cancer cells by inducing apoptosis and arresting the cell
cycle at G0/G1 phase. Mol Med Rep. 10:365–372. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
138
|
Zhong D, Zhang HJ, Jiang YD, Wu P, Qi H,
Cai C, Zheng SB and Dang Q: Saikosaponin-d: A potential
chemotherapeutics in castration resistant prostate cancer by
suppressing cancer metastases and cancer stem cell phenotypes.
Biochem Biophys Res Commun. 474:722–729. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
139
|
Ghosh S: Cisplatin: The first metal based
anticancer drug. Bioorg Chem. 88:1029252019. View Article : Google Scholar : PubMed/NCBI
|
|
140
|
Tsuyoshi H, Wong VKW, Han Y, Orisaka M,
Yoshida Y and Tsang BK: Saikosaponin-d, a calcium mobilizing agent,
sensitizes chemoresistant ovarian cancer cells to cisplatin-induced
apoptosis by facilitating mitochondrial fission and G2/M arrest.
Oncotarget. 8:99825–99840. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
141
|
Tang TT, Jiang L, Zhong Q, Ni ZJ, Thakur
K, Khan MR and Wei ZJ: Saikosaponin D exerts cytotoxicity on human
endometrial cancer ishikawa cells by inducing apoptosis and
inhibiting metastasis through MAPK pathways. Food Chem Toxicol.
177:1138152023. View Article : Google Scholar : PubMed/NCBI
|
|
142
|
Meltzer PS and Helman LJ: New horizons in
the treatment of osteosarcoma. N Engl J Med. 385:2066–2076. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
143
|
Zhao L, Li J, Sun ZB, Sun C, Yu ZH and Guo
X: Saikosaponin D inhibits proliferation of human osteosarcoma
cells via the p53 signaling pathway. Exp Ther Med. 17:488–494.
2019.PubMed/NCBI
|
|
144
|
Gao T, Zhao P, Yu X, Cao S, Zhang B and
Dai M: Use of Saikosaponin D and JNK inhibitor SP600125, alone or
in combination, inhibits malignant properties of human osteosarcoma
U2 cells. Am J Transl Res. 11:2070–2080. 2019.PubMed/NCBI
|
|
145
|
Li Y, Cai T, Zhang W, Zhu W and Lv S:
Effects of Saikosaponin D on apoptosis in human U87 glioblastoma
cells. Mol Med Rep. 16:1459–1464. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
146
|
Liu G, Guan Y, Liu Y, Wang Y, Zhang J, Liu
Y and Liu X: Saikosaponin D inducing apoptosis and autophagy
through the activation of endoplasmic reticulum stress in
glioblastoma. Biomed Res Int. 2022:54895532022. View Article : Google Scholar : PubMed/NCBI
|
|
147
|
McKinnon C, Nandhabalan M, Murray SA and
Plaha P: Glioblastoma: Clinical presentation, diagnosis, and
management. BMJ. 374:n15602021. View Article : Google Scholar : PubMed/NCBI
|
|
148
|
Liang J, Sun J, Liu A, Chen L, Ma X, Liu X
and Zhang C: Saikosaponin D improves chemosensitivity of
glioblastoma by reducing the its stemness maintenance. Biochem
Biophys Rep. 32:1013422022.PubMed/NCBI
|
|
149
|
Northcott PA, Robinson GW, Kratz CP,
Mabbott DJ, Pomeroy SL, Clifford SC, Rutkowski S, Ellison DW,
Malkin D, Taylor MD, et al: Medulloblastoma. Nat Rev Dis Primers.
5:112019. View Article : Google Scholar : PubMed/NCBI
|
|
150
|
Luo J, Wang J, Yang J, Huang W, Liu J, Tan
W and Xin H: Saikosaponin B1 and Saikosaponin D inhibit tumor
growth in medulloblastoma allograft mice via inhibiting the
Hedgehog signaling pathway. J Nat Med. 76:584–593. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
151
|
Shimony S, Stahl M and Stone RM: Acute
myeloid leukemia: 2023 update on diagnosis, risk-stratification,
and management. Am J Hematol. 98:502–526. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
152
|
Huang Y, Su R, Sheng Y, Dong L, Dong Z, Xu
H, Ni T, Zhang ZS, Zhang T, Li C, et al: Small-molecule targeting
of oncogenic FTO demethylase in acute myeloid leukemia. Cancer
Cell. 35:677–691.e10. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
153
|
Li Z, Weng H, Su R, Weng X, Zuo Z, Li C,
Huang H, Nachtergaele S, Dong L, Hu C, et al: FTO plays an
oncogenic role in acute myeloid leukemia as a
N6-methyladenosine RNA demethylase. Cancer Cell.
31:127–141. 2017. View Article : Google Scholar
|
|
154
|
Sun K, Du Y, Hou Y, Zhao M, Li J, Du Y,
Zhang L, Chen C, Yang H, Yan F, et al: Saikosaponin D exhibits
anti-leukemic activity by targeting FTO/m6A signaling.
Theranostics. 11:5831–5846. 2021. View Article : Google Scholar :
|
|
155
|
Wang S, Long S and Wu W: Application of
traditional chinese medicines as personalized therapy in human
cancers. Am J Chin Med. 46:953–970. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
156
|
Luo Y, Wang CZ, Hesse-Fong J, Lin JG and
Yuan CS: Application of Chinese medicine in acute and critical
medical conditions. Am J Chin Med. 47:1223–1235. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
157
|
Xue J, Xu Z, Wang Q, Hou H, Wei L, Zhang
J, Zhao X, Chen L, Ding F, Ma L, et al: Clinical practice
guidelines for prevention and treatment of postoperative
gastrointestinal disorder with Integrated Traditional Chinese and
Western Medicine (2023). J Evid Based Med. 17:207–223. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
158
|
Zhang S, Liu M and Zhao L: Effects of
different Chinese traditional exercises on mental health during the
COVID-19 pandemic: A systematic review and meta-analysis. Front
Public Health. 12:14200352024. View Article : Google Scholar : PubMed/NCBI
|
|
159
|
Li X, Li X, Huang N, Liu R and Sun R: A
comprehensive review and perspectives on pharmacology and
toxicology of saikosaponins. Phytomedicine. 50:73–87. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
160
|
Chen MH, Gu YY, Zhang AL, Sze DM, Mo SL
and May BH: Biological effects and mechanisms of matrine and other
constituents of Sophora flavescens in colorectal cancer. Pharmacol
Res. 171:1057782021. View Article : Google Scholar : PubMed/NCBI
|
|
161
|
Shah MA, Abuzar SM, Ilyas K, Qadees I,
Bilal M, Yousaf R, Kassim RMT, Rasul A, Saleem U, Alves MS, et al:
Ginsenosides in cancer: Targeting cell cycle arrest and apoptosis.
Chem Biol Interact. 382:1106342023. View Article : Google Scholar : PubMed/NCBI
|
|
162
|
Alam P, Imran M, Gupta DK and Akhtar A:
Formulation of transliposomal nanocarrier gel containing strychnine
for the effective management of skin cancer. Gels. 9:8312023.
View Article : Google Scholar : PubMed/NCBI
|
|
163
|
Liu L, Yan J, Cao Y, Yan Y, Shen X, Yu B,
Tao L and Wang S: Proliferation, migration and invasion of triple
negative breast cancer cells are suppressed by berbamine via the
PI3K/Akt/MDM2/p53 and PI3K/Akt/mTOR signaling pathways. Oncol Lett.
21:702021. View Article : Google Scholar
|
|
164
|
Zhou P, Shi W, He XY, Du QY, Wang F and
Guo J: Saikosaponin D: Review on the antitumour effects, toxicity
and pharmacokinetics. Pharm Biol. 59:1480–1489. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
165
|
Zhang F, Chen L, Jin H, Shao J, Wu L, Lu Y
and Zheng S: Activation of Fas death receptor pathway and Bid in
hepatocytes is involved in saikosaponin D induction of
hepatotoxicity. Environ Toxicol Pharmacol. 41:8–13. 2016.
View Article : Google Scholar
|
|
166
|
Farhan M: Green Tea Catechins: Nature's
way of preventing and treating cancer. Int J Mol Sci. 23:107132022.
View Article : Google Scholar : PubMed/NCBI
|
|
167
|
Islam MR, Akash S, Rahman MM, Nowrin FT,
Akter T, Shohag S, Rauf A, Aljohani ASM and Simal-Gandara J: Colon
cancer and colorectal cancer: Prevention and treatment by potential
natural products. Chem Biol Interact. 368:1101702022. View Article : Google Scholar : PubMed/NCBI
|
|
168
|
Yang Z, Xiao T, Li Z, Zhang J and Chen S:
Novel Chemicals derived from tadalafil exhibit PRMT5 inhibition and
promising activities against breast cancer. Int J Mol Sci.
23:48062022. View Article : Google Scholar : PubMed/NCBI
|
|
169
|
Zhao N, Wang W, Jiang H, Qiao Z, Sun S,
Wei Y, Xie X, Li H, Bi X and Yang Z: Natural products and gastric
cancer: cellular mechanisms and effects to change cancer
progression. Anticancer Agents Med Chem. 23:1506–1518. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
170
|
Zhang GS, Hu PY, Li DX, He MZ, Rao XY, Luo
XJ, Wang YS and Wang YR: Formulations, hemolytic and
pharmacokinetic studies on saikosaponin a and saikosaponin d
compound liposomes. Molecules. 20:5889–5907. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
171
|
Shimizu K, Amagaya S and Ogihara Y:
Structural transformation of saikosaponins by gastric juice and
intestinal flora. J Pharmacobiodyn. 8:718–725. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
172
|
Liu J, Xue Y, Sun J, Fu R, Ren S, Zhang Z
and Song R: Pharmacokinetics and oral bioavailability studies of
three saikogenins in rats using a validated UFLC-MS/MS method. J
Chromatogr B Analyt Technol Biomed Life Sci. 1124:265–272. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
173
|
Ye HN, Liu XY and Qin BL: Research
progress of integrated traditional Chinese and Western medicine in
the treatment of advanced gastric cancer. World J Gastrointest
Oncol. 15:69–75. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
174
|
Ma L, Wang B, Long Y and Li H: Effect of
traditional Chinese medicine combined with Western therapy on
primary hepatic carcinoma: A systematic review with meta-analysis.
Front Med. 11:191–202. 2017. View Article : Google Scholar : PubMed/NCBI
|
